Adicet Financial Statements From 2010 to 2024

ACET Stock  USD 1.88  0.00  0.00%   
Adicet Bio financial statements provide useful quarterly and yearly information to potential Adicet Bio investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Adicet Bio financial statements helps investors assess Adicet Bio's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Adicet Bio's valuation are summarized below:
Gross Profit
25 M
Market Capitalization
172.5 M
Enterprise Value Revenue
2.1386
Earnings Share
(3.31)
Quarterly Revenue Growth
(1.00)
There are currently one hundred twenty fundamental signals for Adicet Bio that can be evaluated and compared over time across rivals. All traders should validate Adicet Bio's prevailing fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 77.3 M in 2024. Enterprise Value is likely to gain to about (54.6 M) in 2024

Adicet Bio Total Revenue

0.0

Check Adicet Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Adicet main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.2 M, Interest Expense of 23.8 K or Selling General Administrative of 34.7 M, as well as many exotic indicators such as Price To Sales Ratio of 13.33, Dividend Yield of 0.0155 or PTB Ratio of 0.45. Adicet financial statements analysis is a perfect complement when working with Adicet Bio Valuation or Volatility modules.
  
This module can also supplement Adicet Bio's financial leverage analysis and stock options assessment as well as various Adicet Bio Technical models . Check out the analysis of Adicet Bio Correlation against competitors.
For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.

Adicet Bio Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets363.6 M207.3 M349.7 M
Very volatile
Short and Long Term Debt Total19.9 M20.9 M78.2 M
Pretty Stable
Total Current Liabilities18.3 M19.3 M65.7 M
Slightly volatile
Property Plant And Equipment Net46.4 M44.2 M19 M
Slightly volatile
Current Deferred Revenue3.6 M5.5 M4.3 M
Slightly volatile
Accounts Payable2.5 M2.6 M28.4 M
Slightly volatile
Cash83.8 M159.7 M80.9 M
Slightly volatile
Non Current Assets Total42.8 M45 M115.8 M
Pretty Stable
Cash And Short Term Investments95.9 M159.7 M93.4 M
Slightly volatile
Common Stock Shares Outstanding28.5 M43 M26.2 M
Pretty Stable
Non Current Liabilities Total16.9 M17.8 M87.8 M
Very volatile
Other Current Assets2.4 M2.6 M11.1 M
Slightly volatile
Total Liabilities35.3 M37.1 M144.7 M
Slightly volatile
Total Current Assets177.7 M162.3 M224.4 M
Pretty Stable
Intangible Assets1.3 M1.4 M45.5 M
Pretty Stable
Common Stock3.4 K3.6 K151.3 K
Slightly volatile
Net Receivables371.9 K391.5 K69.5 M
Slightly volatile
Non Currrent Assets Other780.9 K822 K8.2 M
Slightly volatile
Short Term Debt4.8 M3.2 M5.4 M
Slightly volatile
Capital Lease Obligations16.9 M20.9 M21.2 M
Slightly volatile
Net Invested Capital240.8 M170.2 M147.6 M
Slightly volatile
Property Plant And Equipment Gross51.9 M59 M36.5 M
Slightly volatile
Capital Stock3.9 K4.6 K2.6 K
Slightly volatile
Non Current Liabilities Other123.5 K130 K750.8 K
Slightly volatile
Net Working Capital200.3 M143 M113.8 M
Slightly volatile
Other Assets0.80.90.98
Slightly volatile

Adicet Bio Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Expense23.8 K25 K1.5 M
Slightly volatile
Selling General Administrative34.7 M26.5 M42.7 M
Slightly volatile
Other Operating Expenses230.1 M132.6 M279 M
Slightly volatile
Research Development111.3 M106 M29.4 M
Slightly volatile
Cost Of Revenue5.8 M6.1 M203.6 M
Slightly volatile
Total Operating Expenses69.4 M126.5 M66.1 M
Slightly volatile
Interest Income10.5 M10 M2.2 M
Slightly volatile
Reconciled Depreciation3.1 M6.1 M1.8 M
Slightly volatile
Selling And Marketing Expenses4.9 M5.5 MM
Slightly volatile

Adicet Bio Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation21.3 M20.3 M6.8 M
Slightly volatile
Begin Period Cash Flow270.5 M257.7 M82.3 M
Slightly volatile
Depreciation4.2 M6.1 M5.5 M
Pretty Stable
Capital Expenditures3.7 M4.5 M3.6 M
Slightly volatile
End Period Cash Flow84.8 M159.7 M82 M
Slightly volatile
Dividends Paid6.5 M8.1 M6.6 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio13.3313.2327.9015
Pretty Stable
Dividend Yield0.01550.01930.0201
Very volatile
Days Sales Outstanding5.435.72120
Pretty Stable
Stock Based Compensation To Revenue0.650.620.3575
Slightly volatile
EV To Sales4.474.730.9959
Pretty Stable
Inventory Turnover4.032.242.7483
Slightly volatile
Days Of Inventory On Hand202168497
Pretty Stable
Payables Turnover2.212.3234.1919
Slightly volatile
Sales General And Administrative To Revenue0.830.951.2057
Slightly volatile
Research And Ddevelopement To Revenue2.582.572.8274
Slightly volatile
Cash Per Share4.143.71065.8493
Slightly volatile
Payout Ratio0.420.230.263
Slightly volatile
Days Payables Outstanding248157729
Pretty Stable
Income Quality0.710.65691.0016
Pretty Stable
Intangibles To Total Assets0.05030.0530.1804
Slightly volatile
Current Ratio4.828.41357.4475
Slightly volatile
Receivables Turnover54.2951.716.4948
Slightly volatile
Graham Number14.9517.170820.1387
Pretty Stable
Revenue Per Share0.660.78.7268
Slightly volatile
Interest Debt Per Share0.460.485512.9121
Very volatile
Debt To Assets0.180.10090.4068
Very volatile
Days Of Payables Outstanding248157729
Pretty Stable
Dividend Payout Ratio0.420.230.263
Slightly volatile
Ebt Per Ebit1.081.0760.9513
Very volatile
Quick Ratio4.148.28086.7906
Slightly volatile
Net Income Per E B T0.60.860.7821
Slightly volatile
Cash Ratio8.698.28083.9498
Slightly volatile
Days Of Inventory Outstanding202168497
Pretty Stable
Days Of Sales Outstanding5.435.72120
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio0.811.04761.0165
Slightly volatile
Fixed Asset Turnover0.560.5927.9538
Slightly volatile
Debt Ratio0.180.10090.4068
Very volatile
Price Sales Ratio13.3313.2327.9015
Pretty Stable
Asset Turnover0.08260.08690.5993
Slightly volatile
Gross Profit Margin0.760.720.533
Slightly volatile
Operating Cycle277174613
Pretty Stable

Adicet Bio Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap77.3 M81.4 M788.7 M
Slightly volatile

Adicet Fundamental Market Drivers

Cash And Short Term Investments159.7 M

Adicet Upcoming Events

20th of March 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Adicet Bio Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Adicet Bio income statement, its balance sheet, and the statement of cash flows. Adicet Bio investors use historical funamental indicators, such as Adicet Bio's revenue or net income, to determine how well the company is positioned to perform in the future. Although Adicet Bio investors may use each financial statement separately, they are all related. The changes in Adicet Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Adicet Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Adicet Bio Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Adicet Bio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue5.5 M3.6 M
Total Revenue25 M0.0
Cost Of Revenue6.1 M5.8 M
Stock Based Compensation To Revenue 0.62  0.65 
Sales General And Administrative To Revenue 0.95  0.83 
Research And Ddevelopement To Revenue 2.57  2.58 
Capex To Revenue(0.77)(0.73)
Revenue Per Share 0.70  0.66 
Ebit Per Revenue(3.34)(3.51)
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Adicet Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Adicet Bio's short interest history, or implied volatility extrapolated from Adicet Bio options trading.

Pair Trading with Adicet Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Adicet Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adicet Bio will appreciate offsetting losses from the drop in the long position's value.

Moving against Adicet Stock

  0.76DD Dupont De Nemours Earnings Call This WeekPairCorr
  0.7MMM 3M Company Earnings Call This WeekPairCorr
  0.7BAC Bank of America Sell-off TrendPairCorr
  0.69WMT Walmart Financial Report 16th of May 2024 PairCorr
  0.68XOM Exxon Mobil Corp Earnings Call TomorrowPairCorr
The ability to find closely correlated positions to Adicet Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adicet Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adicet Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adicet Bio to buy it.
The correlation of Adicet Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adicet Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adicet Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Adicet Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Adicet Bio is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Adicet Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Adicet Bio Stock. Highlighted below are key reports to facilitate an investment decision about Adicet Bio Stock:
Check out the analysis of Adicet Bio Correlation against competitors.
For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.
Note that the Adicet Bio information on this page should be used as a complementary analysis to other Adicet Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for Adicet Stock analysis

When running Adicet Bio's price analysis, check to measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Is Adicet Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adicet Bio. If investors know Adicet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adicet Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.31)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.31)
Return On Equity
(0.62)
The market value of Adicet Bio is measured differently than its book value, which is the value of Adicet that is recorded on the company's balance sheet. Investors also form their own opinion of Adicet Bio's value that differs from its market value or its book value, called intrinsic value, which is Adicet Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adicet Bio's market value can be influenced by many factors that don't directly affect Adicet Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adicet Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adicet Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adicet Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.